Skip to main content
Equibles

DIMENSIONAL FUND ADVISORS LP

Position in TLRY — Tilray Brands, Inc.

CIK 354204 AUSTIN, TX
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$243,717
-$324,368 QoQ
Shares Held
54,280
-38.2% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 235 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 93% Shared 1% None 6%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. TLRY ranks #42 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 25,417,271 $625,519,037
2 VTRS
Viatris Inc
 29,970,094 $475,925,092
3 UTHR
UNITED THERAPEUTICS Corp
 527,904 $286,034,221
4 ALKS
Alkermes plc.
 4,194,873 $219,811,343
5 LNTH
Lantheus Holdings, Inc.
 1,466,260 $162,666,882
6 ZTS
Zoetis Inc.
 2,173,278 $156,171,754
7 PBH
Prestige Consumer Healthcare Inc.
 2,661,291 $125,799,224
8 NBIX
Neurocrine Biosciences Inc
 732,877 $123,519,088

All Filings in TLRY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $243,717 54,280
2026-03-31 $568,085 87,803
2025-12-31 $433,458 48,002
2025-09-30 $612,883 354,268
2025-06-30 $153,183 373,618
2025-03-31 $728,175 1,103,297
2024-12-31 $2,890,002 2,172,935
2024-09-30 $2,469,924 1,403,366
2024-06-30 $2,794,131 1,683,212
2024-03-31 $5,029,379 2,036,186
2023-12-31 $1,247,273 542,293
2023-09-30 $387,449 162,113
2022-03-31 $421,817 54,288
2021-12-31 $21,489,929 3,056,889
2021-09-30 $45,616,804 4,040,461
2021-06-30 $10,718,728 592,850